☆ 4.6 Article

On the Road towards Small-Molecule Programmed Cell Death 1 Ligand 1 Positron Emission Tomography Tracers: A Ligand-Based Drug Design Approach

PHARMACEUTICALS (2023)

Related references

Note: Only part of the references are listed.

Article Chemistry, Medicinal

Evaluation of a Radiolabeled Macrocyclic Peptide as Potential PET Imaging Probe for PD-L1

Nedra Jouini et al.

Summary: The interaction between PD-1 and PD-L1 affects T-cell deactivation and cancer proliferation. Radiotracers provide information on the expression of PD-L1, allowing personalized treatment. This study aimed to develop a PD-L1-specific PET radiotracer but found that the previous peptide was not suitable.

CHEMMEDCHEM (2022)

Add to Collection

Review Chemistry, Medicinal

Development of Radiotracers for Imaging of the PD-1/PD-L1 Axis

Fabian Krutzek et al.

Summary: Immune checkpoint inhibitor (ICI) therapy is emerging as a major treatment option for various cancers. PD-1 and PD-L1 are key targets for ICI, with PD-L1 serving as a reproducible biomarker for therapy decisions and monitoring success. However, PD-L1 expression is heterogeneous and dynamic, making standard diagnostics inadequate. Molecular imaging techniques like PET and SPECT offer advantages in addressing the challenges of heterogeneous checkpoint expression over time. This article provides an overview of existing imaging agents and discusses their pros and cons. Possible future directions for developing new imaging agents for PD-1/PD-L1 status in cancer patients are also presented.

PHARMACEUTICALS (2022)

Add to Collection

Article Oncology

Immuno-PET imaging of 68Ga-labeled nanobody Nb109 for dynamic monitoring the PD-L1 expression in cancers

Qingzhu Liu et al.

Summary: The study assessed a non-blocking nanobody tracer's specificity and dynamic monitoring property to PD-L1, demonstrating its high sensitivity and specificity in monitoring PD-L1 expression. The tracer showed potential for guiding immunotherapy and immunochemotherapy for refractory cancers.

CANCER IMMUNOLOGY IMMUNOTHERAPY (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Molecular Mechanism of Small-Molecule Inhibitors in Blocking the PD-1/PD-L1 Pathway through PD-L1 Dimerization

Yan Guo et al.

Summary: The study systematically evaluated the inhibitory mechanism of BMS-200-related small-molecule inhibitors in PD-L1 dimer using molecular dynamics simulations and binding free energy analysis. The results show that these inhibitors can promote the dimerization of PD-L1 and mainly bind with specific regions of the PD-L1 dimer. Additionally, compared to (S)-BMS-200, (R)-BMS-200 is more likely to form hydrogen bonds with charged residues.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Add to Collection

Review Cell Biology

T Cell Dysfunction and Exhaustion in Cancer

Zhen Zhang et al.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)

Add to Collection

Article Oncology

The PET-Tracer 89Z -Df-IAB22M2C Enables Monitoring of Intratumoral CD8 T-cell Infiltrates in Tumor-Bearing Humanized Mice after T-cell Bispecific Antibody Treatment

Christoph M. Griessinger et al.

CANCER RESEARCH (2020)

Add to Collection

Review Oncology

Review of Indications of FDA-Approved Immune Checkpoint Inhibitors per NCCN Guidelines with the Level of Evidence

Raju K. Vaddepally et al.

CANCERS (2020)

Add to Collection

Article Chemistry, Multidisciplinary

Computational Insight Into the Small Molecule Intervening PD-L1 Dimerization and the Potential Structure-Activity Relationship

Danfeng Shi et al.

FRONTIERS IN CHEMISTRY (2019)

Add to Collection

Article Chemistry, Medicinal

Pitfalls and solutions of the fully-automated radiosynthesis of [11C]metoclopramide

Verena Pichler et al.

EJNMMI RADIOPHARMACY AND CHEMISTRY (2019)

Add to Collection

Article Radiology, Nuclear Medicine & Medical Imaging

Synthesis and Biologic Evaluation of a Novel F-18-Labeled Adnectin as a PET Radioligand for Imaging PD-L1 Expression

David J. Donnelly et al.

JOURNAL OF NUCLEAR MEDICINE (2018)

Add to Collection

Article Biochemistry & Molecular Biology

Zr-89-atezolizumab imaging as a non-invasive approach to assess clinical response to PD-L1 blockade in cancer

Frederike Bensch et al.

NATURE MEDICINE (2018)

Add to Collection

Article Radiology, Nuclear Medicine & Medical Imaging

In Vivo Imaging of the Programmed Death Ligand 1 by 18F PET

Dinko E. Gonzalez Trotter et al.

JOURNAL OF NUCLEAR MEDICINE (2017)

Add to Collection

Article Radiology, Nuclear Medicine & Medical Imaging

LogP, a yesterday's value?

Chrysoula Vraka et al.

NUCLEAR MEDICINE AND BIOLOGY (2017)

Add to Collection

Article Medicine, Research & Experimental

High-Resolution PET Imaging with Therapeutic Antibody-based PD-1/PD-L1 Checkpoint Tracers

Michael Hettich et al.

THERANOSTICS (2016)

Add to Collection

Article Chemistry, Medicinal

Setting expectations in molecular optimizations: Strengths and limitations of commonly used composite parameters

Michael D. Shultz

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2013)

Add to Collection

Article Chemistry, Multidisciplinary

Carbamate synthesis from amines and dialkyl carbonate over inexpensive and clean acidic catalyst-Sulfamic acid

Bo Wang et al.

CHINESE CHEMICAL LETTERS (2010)

Add to Collection

Article Chemistry, Medicinal

Validation of Molecular Docking Programs for Virtual Screening against Dihydropteroate Synthase

Kirk E. Hevener et al.

JOURNAL OF CHEMICAL INFORMATION AND MODELING (2009)

Add to Collection

Review Chemistry, Medicinal

Structure-brain exposure relationships

Stephen A. Hitchcock et al.

JOURNAL OF MEDICINAL CHEMISTRY (2006)

Add to Collection

Review Biochemical Research Methods

Method for measuring the logarithm of the octanol-water partition coefficient by using short octadecyl-poly(vinyl alcohol) high-performance liquid chromatography columns

SF Donovan et al.

JOURNAL OF CHROMATOGRAPHY A (2002)

Add to Collection

© Peeref 2019-2024. All rights reserved.